Neurotoxicity due to prophylactic cranial irradiation for small‑cell lung cancer: A retrospective analysis
- Authors:
- Yoshiro Nakahara
- Yusuke Takagi
- Yusuke Okuma
- Yukio Hosomi
- Tatsuru Okamura
- Masahiko Shibuya
- Noriyuki Masuda
View Affiliations
Affiliations: Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo 113‑8677, Japan, Department of Respiratory Medicine, Kitasato University School of Medicine, Sagamihara, Kanagawa 252‑0239, Japan
- Published online on: June 11, 2015 https://doi.org/10.3892/mco.2015.581
-
Pages:
1048-1052
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Prophylactic cranial irradiation (PCI) is an established part of standard therapy for small‑cell lung cancer (SCLC). However, the concerns regarding severe late neurotoxicity following PCI have not yet been systematically investigated. Therefore, the aim of this study was to investigate the neurocognitive functioning of SCLC patients treated with PCI. Limited‑disease SCLC (LD‑SCLC) patients (n=40) treated at Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital (Tokyo, Japan) between January, 2004 and December, 2011 were retrospectively reviewed. A total of 18 LD‑SCLC patients were treated with PCI (median age, 65.5 years; range, 52‑75 years), whereas 22 LD‑SCLC patients did not receive PCI (median age, 65.5 years; range, 57‑84 years). The median follow‑up for PCI and non‑PCI patients was 22 months (range, 4‑85 months) and 14.5 months (range, 2‑49 months), respectively. Brain metastases occurred in 6 (33%) PCI patients and 11 (50%) non‑PCI patients. In the PCI group, dementia occurred in 5 of the 12 PCI patients without brain metastases (42%, 3‑40 months after PCI) and in 1 of the 11 non‑PCI patients without brain metastases (9%, 4 months after initial treatment). The frequency of dementia in the PCI group was significantly higher compared with that in the non‑PCI group (P=0.0357). In the PCI group, all the patients who developed dementia were aged >65 years (range, 66‑75 years). Gait disturbance appeared in 25% of the PCI patients without brain metastases (9‑27 months after PCI); these patients were also aged >65 years. Patients aged >65 years were significantly more likely to develop dementia (P=0.0028) and gait disturbance (P=0.0291). Therefore, neurotoxicity due to PCI tends to appear more frequently in older patients.
View References
|
1
|
Glantz MJ, Choy H and Yee L: Prophylactic
cranial irradiation in small cell lung cancer: rationale, results
and recommendations. Semin Oncol. 24:477–483. 1997.PubMed/NCBI
|
|
2
|
Arriagada R, Le Chevalier T, Borie F, et
al: Prophylactic cranial irradiation for patients with small-cell
lung cancer in complete remission. J Natl Cancer Inst. 87:183–190.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gregor A, Cull A, Stephens RJ, et al:
Prophylactic cranial irradiation is indicated following complete
response to induction therapy in small cell lung cancer: result of
a multicenter randomized trial. Eur J Cancer. 33:1752–1758. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Laplanche A, Monnet I, Santos-Miranda JA,
et al: Controlled clinical trial of prophylactic cranial
irradiation for patients with small-cell lung cancer in complete
remission. Lung Cancer. 21:193–201. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Auperin A, Arriagada R, Pignon JP, et al:
Prophylactic cranial irradiation for patients with small-cell lung
cancer in complete remission. N Engl J Med. 341:476–484. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Slotman B, Faivre-Finn C, Kramer G, et al:
Prophylactic cranial irradiation in extensive small-cell lung
cancer. N Engl J Med. 357:664–672. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schild SE, Foster NR, Meyers JP, et al:
North Central Cancer Treatment Group: Prophylactic cranial
irradiation in small-cell lung cancer: findings from a North
Central Cancer Treatment Group pooled analysis. Ann Oncol.
23:2919–2924. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yokota M, Miyanaga K, Yonemura K, et al:
Declining of memory functions of normal elderly persons. Psychiatry
Clin Neurosci. 54:217–225. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Katoh S, Simogaki H, Onodera A, et al:
Development of the revised version of Hasegawa's Dementia Scale
(HDS-R). Jpn J Geriat Psychiatry. 2:1339–1347. 1991.(In
Japanese).
|
|
10
|
Ball DL and Matthews JP: Prophylactic
cranial irradiation: more questions than answers. Semin Radiat
Oncol. 5:61–68. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Welzel T, Niethammer A, Mende U, et al:
Diffusion tensor imaging screening of radiation-induced changes in
the white matter after prophylactic cranial irradiation of patients
with small cell lung cancer: first results of a prospective study.
AJNR Am J Neuroradiol. 29:379–383. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Grosshans DR, Meyers CA, Allen PK, et al:
Neurocognitive function in patients with small cell lung cancer:
effect of prophylactic cranial irradiation. Cancer. 112:589–595.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gondi V, Paulus R, Bruner DW, et al:
Decline in tested and self-reported cognitive functioning after
prophylactic cranial irradiation for lung cancer: pooled secondary
analysis of Radiation Therapy Oncology Group randomized trials 0212
and 0214. Int J Radiat Oncol Biol Phys. 86:656–664. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Le Péchoux C, Dunant A, Senan S, et al:
Prophylactic Cranial Irradiation (PCI) Collaborative Group:
Standard-dose versus higher-dose prophylactic cranial irradiation
(PCI) in patients with limited-stage small-cell lung cancer in
complete remission after chemotherapy and thoracic radiotherapy
(PCI 99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01): a
randomised clinical trial. Lancet Oncol. 10:467–474. 2009.
View Article : Google Scholar : PubMed/NCBI
|
